Serum levels of vitamin D metabolites in children receiving total parenteral nutrition. 1986

S Kimura, and O Nose, and T Harada, and I Maki, and S Kanaya, and H Tajiri, and K Shimizu, and K Yamaoka, and Y Seino, and H Yabuuchi

Serum levels of 25-hydroxyvitamin D (25-OHD) and 1,25-dihydroxyvitamin D (1,25-(OH)2D) were measured on 19 occasions in seven children receiving total parenteral nutrition (TPN). The daily intakes of vitamin D3 ranged from 44 to 540 IU/day, and all serum samples were obtained after the same daily intake of vitamin D3 for more than 1 month. There was a significant positive correlation between serum 25-OHD levels and parenteral vitamin D3 intakes (r = 0.90, p less than 0.01). In this study, serum 25-OHD levels in all cases taking 200 to 360 IU/day of vitamin D3 were within the normal range. On the other hand, no significant correlation was found between serum 1,25-(OH)2D levels and vitamin D3 intakes, and serum 1,25-(OH)2D levels were normal or elevated in all cases.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D009751 Nutritional Requirements The amounts of various substances in food needed by an organism to sustain healthy life. Dietary Requirements,Nutrition Requirements,Dietary Requirement,Nutrition Requirement,Nutritional Requirement,Requirement, Dietary,Requirement, Nutrition,Requirement, Nutritional,Requirements, Dietary,Requirements, Nutrition,Requirements, Nutritional
D010289 Parenteral Nutrition, Total The delivery of nutrients for assimilation and utilization by a patient whose sole source of nutrients is via solutions administered intravenously, subcutaneously, or by some other non-alimentary route. The basic components of TPN solutions are protein hydrolysates or free amino acid mixtures, monosaccharides, and electrolytes. Components are selected for their ability to reverse catabolism, promote anabolism, and build structural proteins. Hyperalimentation, Parenteral,Intravenous Hyperalimentation,Nutrition, Total Parenteral,Parenteral Hyperalimentation,Total Parenteral Nutrition,Hyperalimentation, Intravenous
D002112 Calcifediol The major circulating metabolite of VITAMIN D3. It is produced in the LIVER and is the best indicator of the body's vitamin D stores. It is effective in the treatment of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties. 25-Hydroxycholecalciferol,25-Hydroxyvitamin D 3,25-Hydroxycholecalciferol Monohydrate,25-Hydroxyvitamin D3,Calcidiol,Calcifediol Anhydrous,Calcifediol, (3 alpha,5Z,7E)-Isomer,Calcifediol, (3 beta,5E,7E)-Isomer,Calderol,Dedrogyl,Hidroferol,25 Hydroxycholecalciferol,25 Hydroxycholecalciferol Monohydrate,25 Hydroxyvitamin D 3,25 Hydroxyvitamin D3,Anhydrous, Calcifediol,Monohydrate, 25-Hydroxycholecalciferol
D002117 Calcitriol The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption. 1 alpha,25-Dihydroxycholecalciferol,1 alpha,25-Dihydroxyvitamin D3,1, 25-(OH)2D3,1,25(OH)2D3,1,25-Dihydroxycholecalciferol,1,25-Dihydroxyvitamin D3,1 alpha, 25-dihydroxy-20-epi-Vitamin D3,1,25(OH)2-20epi-D3,1,25-dihydroxy-20-epi-Vitamin D3,20-epi-1alpha,25-dihydroxycholecaliferol,Bocatriol,Calcijex,Calcitriol KyraMed,Calcitriol-Nefro,Decostriol,MC-1288,MC1288,Osteotriol,Renatriol,Rocaltrol,Silkis,Sitriol,Soltriol,Tirocal,1 alpha,25 Dihydroxyvitamin D3,1,25 Dihydroxycholecalciferol,1,25 Dihydroxyvitamin D3,1,25 dihydroxy 20 epi Vitamin D3,Calcitriol Nefro,D3, 1 alpha,25-Dihydroxyvitamin,D3, 1,25-Dihydroxyvitamin,D3, 1,25-dihydroxy-20-epi-Vitamin,KyraMed, Calcitriol,MC 1288
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002762 Cholecalciferol Derivative of 7-dehydroxycholesterol formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. It differs from ERGOCALCIFEROL in having a single bond between C22 and C23 and lacking a methyl group at C24. Vitamin D 3,(3 beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol,Calciol,Cholecalciferols,Vitamin D3
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Kimura, and O Nose, and T Harada, and I Maki, and S Kanaya, and H Tajiri, and K Shimizu, and K Yamaoka, and Y Seino, and H Yabuuchi
January 2001, Journal of clinical gastroenterology,
S Kimura, and O Nose, and T Harada, and I Maki, and S Kanaya, and H Tajiri, and K Shimizu, and K Yamaoka, and Y Seino, and H Yabuuchi
March 1983, Annals of surgery,
S Kimura, and O Nose, and T Harada, and I Maki, and S Kanaya, and H Tajiri, and K Shimizu, and K Yamaoka, and Y Seino, and H Yabuuchi
January 1993, JPEN. Journal of parenteral and enteral nutrition,
S Kimura, and O Nose, and T Harada, and I Maki, and S Kanaya, and H Tajiri, and K Shimizu, and K Yamaoka, and Y Seino, and H Yabuuchi
September 1977, Archives of surgery (Chicago, Ill. : 1960),
S Kimura, and O Nose, and T Harada, and I Maki, and S Kanaya, and H Tajiri, and K Shimizu, and K Yamaoka, and Y Seino, and H Yabuuchi
February 1985, Journal of pediatric gastroenterology and nutrition,
S Kimura, and O Nose, and T Harada, and I Maki, and S Kanaya, and H Tajiri, and K Shimizu, and K Yamaoka, and Y Seino, and H Yabuuchi
January 1987, JPEN. Journal of parenteral and enteral nutrition,
S Kimura, and O Nose, and T Harada, and I Maki, and S Kanaya, and H Tajiri, and K Shimizu, and K Yamaoka, and Y Seino, and H Yabuuchi
October 1996, Neuroradiology,
S Kimura, and O Nose, and T Harada, and I Maki, and S Kanaya, and H Tajiri, and K Shimizu, and K Yamaoka, and Y Seino, and H Yabuuchi
May 2015, JPEN. Journal of parenteral and enteral nutrition,
S Kimura, and O Nose, and T Harada, and I Maki, and S Kanaya, and H Tajiri, and K Shimizu, and K Yamaoka, and Y Seino, and H Yabuuchi
January 1976, Acta chirurgica Scandinavica. Supplementum,
S Kimura, and O Nose, and T Harada, and I Maki, and S Kanaya, and H Tajiri, and K Shimizu, and K Yamaoka, and Y Seino, and H Yabuuchi
August 1985, The British journal of surgery,
Copied contents to your clipboard!